Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Febrile Neutropenia × N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1 Classical hematology 1

Conditions

Colorectal Neoplasms 3 Neoplasms 2 Peripheral Nervous System Diseases 1 Neutropenia 1 Neoplasm Metastasis 1 Febrile Neutropenia 1

Interventions

Filgrastim 2 pegfilgrastim 1 Vancomycin 1 Sodium Chloride 1 Piperacillin, Tazobactam Drug Combination 1 N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid 1 Meropenem 1 Linezolid 1 Cefepime 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01619423 2018-07-06

PLIANT

Egetis Therapeutics

Phase 1/2 Completed

186 enrolled 12 charts

Classical hematologyGastrointestinal

Neutropenia, Colorectal Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡